--2025/Q1-- / 4.226M--
--2024/Q4-- / 7.092M--
Nov 12, 20242024/Q31.750M / 2.929M--
Aug 1, 20242024/Q21.647M / 3.436M--
May 2, 20242024/Q11.130M / 1.401M--
US Stock MarketDetailed Quotes
LXRX Lexicon Pharmaceuticals
- 0.820
- +0.013+1.56%
Trading Nov 21 09:31 ET
296.42MMarket Cap-1108P/E (TTM)
0.820High0.801Low93.77KVolume0.801Open0.807Pre Close75.54KTurnover0.05%Turnover RatioLossP/E (Static)361.49MShares3.73052wk High1.66P/B149.36MFloat Cap0.79452wk Low--Dividend TTM182.14MShs Float344.750Historical High--Div YieldTTM2.30%Amplitude0.794Historical Low0.805Avg Price1Lot Size
Lexicon Pharmaceuticals Key Stats
Lexicon Pharmaceuticals Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 2.93M | 1.75M | -1.18M |
| Miss Est. | +1708.20% | +980.25% | -40.26% |
| EPS | -0.17 | -0.18 | -0.01 |
| Miss Est. | +20.96% | +14.29% | -8.50% |
Analyst Rating
Nov 5, 2024
Lexicon Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Lexicon Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data